πŸ‡ΊπŸ‡Έ FDA
Patent

US 9469637

Nitrogenated heterocyclic compound

granted A61KA61K31/498A61K31/555

Quick answer

US patent 9469637 (Nitrogenated heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/498, A61K31/555, A61K9/20, A61P